ConductScience.org, home

Paper17545598

T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation.

Oh SM and 8 others. Cancer Res, 2007. Cited by 58 papers, by iCite.

Cite this record

ConductScience Library. T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation. Papers, record 17545598. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17545598

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation.
PubMed
Journal
Cancer Res
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
1.22
iCite
Revised in PubMed
2021-12-03
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Oh SMSang-Muk
2Zhu FFeng
3Cho YYYong-Yeon
4Lee KWKi Won
5Kang BSBong Seok
6Kim HGHong-Gyum
7Zykova TTatyana
8Bode AMAnn M
9Dong ZZigang

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell Transformation, NeoplasticMajor topic
Genes, rasMajor topic
MAP Kinase Signaling SystemMajor topic
Mitogen-Activated Protein Kinase 8Major topic
Protein Serine-Threonine KinasesMajor topic
Adaptor Proteins, Signal Transducing
Animals
DNA, Complementary
Enzyme Activation
Humans
Melanoma
Mice
Mice, Knockout
Mitogen-Activated Protein Kinase Kinases
Phosphorylation
Swiss 3T3 Cells
Transcription Factor AP-1
Transfection
Ultraviolet Rays

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA111356NCI NIH HHSUnited StatesR01CA111356PubMed and NIHNIH RePORTER
CA27502NCI NIH HHSUnited StatesP01CA027502PubMed and NIHNIH RePORTER
CA77646NCI NIH HHSUnited StatesR01CA077646PubMed and NIHNIH RePORTER
CA81064NCI NIH HHSUnited StatesR01CA081064PubMed and NIHNIH RePORTER
CA88961NCI NIH HHSUnited StatesP01CA088961PubMed and NIHNIH RePORTER
R37CA081064NIHNIH RePORTER

Download CSV of grants

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
42079338Advances in T-Lymphokine-activated Killer Cell-originated Protein Kinase Research in Cancer Over the Past Thirty Years.J Cancer Prev2026https://conductscience.org/library/papers/42079338PubMed
41362722The Roles of TOPK in Tumorigenesis and Development: Structure, Mechanisms, Pathways, and Therapeutic Implications.Int J Biol Sci2026https://conductscience.org/library/papers/41362722PubMed
40301429Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancer.Sci Rep2025https://conductscience.org/library/papers/40301429PubMed
40224460Sinomenine Inhibits TOPK To Ameliorate Psoriasiform Dermatitis.ACS Omega2025https://conductscience.org/library/papers/40224460PubMed
39803648Protein tyrosine phosphatase PTPH1 potentiates receptor tyrosine kinase HER2 oncogenesis via a PDZ-coupled and phosphorylation-driven scaffold.Am J Cancer Res2024https://conductscience.org/library/papers/39803648PubMed
39649886Unraveling the role of PBK in glioblastoma: from molecular mechanisms to therapeutic targets.Ann Med Surg (Lond)2024https://conductscience.org/library/papers/39649886PubMed
35203508PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers.Biomedicines2022https://conductscience.org/library/papers/35203508PubMed
34859058Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort.Front Mol Biosci2021https://conductscience.org/library/papers/34859058PubMed
34227361[Affinity chromatography based phosphoproteome research on lung cancer cells and its application].Se Pu2021https://conductscience.org/library/papers/34227361PubMed
34066486PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential.Cancers (Basel)2021https://conductscience.org/library/papers/34066486PubMed
33670114PBK/TOPK: A Therapeutic Target Worthy of Attention.Cells2021https://conductscience.org/library/papers/33670114PubMed
33431797PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma.Oncogenesis2021https://conductscience.org/library/papers/33431797PubMed
33093441Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma.Signal Transduct Target Ther2020https://conductscience.org/library/papers/33093441PubMed
32277233Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032.Oncogene2020https://conductscience.org/library/papers/32277233PubMed
32237067PBK attenuates paclitaxel-induced autophagic cell death by suppressing p53 in H460 non-small-cell lung cancer cells.FEBS Open Bio2020https://conductscience.org/library/papers/32237067PubMed
31985814Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T-lymphokine-activated killer cell-originated protein kinase.Br J Pharmacol2020https://conductscience.org/library/papers/31985814PubMed
30898980Baicalin suppresses lung cancer growth by targeting PDZ-binding kinase/T-LAK cell-originated protein kinase.Biosci Rep2019https://conductscience.org/library/papers/30898980PubMed
30356039T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics.Cell Death Dis2018https://conductscience.org/library/papers/30356039PubMed
30292353Emerging Contributions of Cancer/Testis Antigens to Neoplastic Behaviors.Trends Cancer2018https://conductscience.org/library/papers/30292353PubMed
29904102Targeting PRPK and TOPK for skin cancer prevention and therapy.Oncogene2018https://conductscience.org/library/papers/29904102PubMed

See all 41 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HRAS3265PubTator's text mininghttps://conductscience.org/library/genes/3265NCBI Gene
JUN3725PubTator's text mininghttps://conductscience.org/library/genes/3725NCBI Gene
MAPK85599PubTator's text mininghttps://conductscience.org/library/genes/5599NCBI Gene
MAPK8IP19479PubTator's text mininghttps://conductscience.org/library/genes/9479NCBI Gene
PBK55872PubTator's text mininghttps://conductscience.org/library/genes/55872NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17545598

GET https://conductscience.org/api/papers/v1/17545598/cited_by?page=2